Insider · CIK 0001551965
Gaurav Aggarwal
Files at GERN (GERON CORP), UNCY (Unicycive Therapeutics, Inc.). First filing -, latest -.
Gaurav Aggarwal files SEC Form 4 as director at GERN (GERON CORP), and also at UNCY (Unicycive Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Gaurav Aggarwal has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 25, 2025 | UNCY Unicycive Therapeutics, Inc. | CConversion Common Stockindirect: By Vivo Opportunity Fund Holdings L.P. | +652,900 | - | - | 1,789,915 | Aug 26, 2025 |
| Aug 25, 2025 | UNCY Unicycive Therapeutics, Inc. | DDisposition to issuer Series A-2 Prime Preferred Stockderivativeindirect: By Vivo Opportunity Fund Holdings L.P. | -3,199 | $1,000.00 | $3.2M | 0 | Aug 26, 2025 |
| Jul 28, 2025 | UNCY Unicycive Therapeutics, Inc. | AGrant or award Stock Optionsderivative | +21,200 | $0.00 | $0 | 39,200 | Jul 30, 2025 |
| May 21, 2025 | GERN GERON CORP | AGrant or award Stock Option (right to buy)derivative | +180,000 | $0.00 | $0 | 180,000 | May 22, 2025 |
| Feb 18, 2025 | UNCY Unicycive Therapeutics, Inc. | CConversion Common Stockindirect: By Vivo Opportunity Fund Holdings L.P. | +1,400,000 | - | - | 11,370,152 | Feb 19, 2025 |
| Feb 18, 2025 | UNCY Unicycive Therapeutics, Inc. | DDisposition to issuer Series A-2 Prime Preferred Stockderivativeindirect: By Vivo Opportunity Fund Holdings L.P. | -686 | $1,000.00 | $686k | 3,119 | Feb 19, 2025 |
Questions about Gaurav Aggarwal
Answered from the filings on this page, as of the latest one.
Is Gaurav Aggarwal buying or selling?
Gaurav Aggarwal has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Gaurav Aggarwal's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Gaurav Aggarwal has 0.
Where does Gaurav Aggarwal file Form 4?
Gaurav Aggarwal has filed Form 4 at GERN (GERON CORP); UNCY (Unicycive Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.